Doliver Advisors LP Takes $1.41 Million Position in UnitedHealth Group Incorporated $UNH

Doliver Advisors LP purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, Holdings Channel reports. The firm purchased 4,533 shares of the healthcare conglomerate’s stock, valued at approximately $1,414,000.

A number of other hedge funds have also modified their holdings of the business. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $42,000. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $42,000. Finally, Investment Management Corp VA ADV acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $44,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $352.61 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market capitalization of $319.35 billion, a P/E ratio of 15.28, a PEG ratio of 2.31 and a beta of 0.45. The business has a 50 day moving average price of $291.98 and a 200 day moving average price of $369.67.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the previous year, the company posted $6.80 EPS. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.